U.S. Food and Drug Administration
FDA.gov Website Refresh
FDA is pleased to announce the launch of our newly redesigned public website. We are making website improvements to provide a more modern and customer-centric web experience.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Northfork Bison Distributions Inc. is Voluntarily Recalling Bison Burgers & Bison Ground Because of Possible Health Risk
Food & Beverages
Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Over-The-Counter Ophthalmic Products Sold By Accutome, Focus Laboratories, Grandall Distributing Co. Inc. And Prestige
Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Over-The-Counter Ophthalmic Products Sold By Natural Ophthalmics And TRP Company, Inc.
Ensuring Safe, Effective Medical Device Sterilization in Manufacturing
The FDA is working to help ensure this process is carried out in a safe and effective manner.
How the FDA Uses Science to Speed Medical Device Innovation
The MDDT program streamlines the medical device development and review process.
Ensuring Drug Manufacturing Quality in Partnership with EU Regulators
The Mutual Recognition Agreement (MRA) with the European Union (EU), allows FDA to more effectively deploy our inspectional resources across the globe.
Submitting Next Generation Sequencing Data to the Division of Antiviral Products Guidance for Industry Technical Specifications Document
Providing Regulatory Submissions in Electronic Format — Certain Human Pharmaceutical Product Applications and Related Submissions Using the eCTD Specifications Guidance for Industry